Shanghai Clayton Biotechnology Co., Ltd. Clayton Brief Introduction.

Adhering to the corporate mission of "caring for life scientifically", Claessen focuses on the world's leading biotechnology, focuses on the research and development of tumor biotherapy technology, actively promotes the progress and development in the application field of biological anticancer technology, leads the biological anticancer industry, and meticulously builds Claessen's scientific and technological brand.

Claessen has gathered many first-class academic authorities and medical experts in oncology, immunology, biotechnology and other fields, including 5 experts enjoying special allowance from the State Council, 9 doctoral supervisors and 48 chief physicians. Claessen has also introduced a powerful scientific research and technical force composed of many foreign biologists, doctoral students studying in Europe and America, and excellent biomedical graduates from well-known universities in China, which has provided a strong guarantee for the continuous progress and long-term development of Claessen's core technologies.

In terms of advanced technical cooperation, Claessen has carried out various forms of technical cooperation and comprehensive exchanges with many famous academic and scientific research institutions at home and abroad. In laboratory construction, Claessen invested heavily in building the national GMP standard laboratory, and purchased a large number of advanced experimental equipment, maintaining Claessen's leading position in the core technology industry.

Claessen strictly abides by the international competition law and business standards, constantly innovates its business model, unswervingly adheres to the business principle of "honesty-based, win-win cooperation and innovative development", and works together with its partners to improve the quality of human life, serve human health and benefit human society!